These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2837265)

  • 61. Immunomodification and the expression of virulence in mice by defined strains of Semliki Forest virus: the effects of cyclophosphamide.
    Bradish CJ; Allner K; Fitzgeorge R
    J Gen Virol; 1975 Aug; 28(2):225-37. PubMed ID: 1176966
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Blood brain barrier disturbance and immunoglobulin G levels in the cerebrospinal fluid of the mouse following peripheral infection with the demyelinating strain of Semliki Forest virus.
    Parsons LM; Webb HE
    J Neurol Sci; 1982 Dec; 57(2-3):307-18. PubMed ID: 6298371
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Humoral and cell-mediated immune mechanisms in the production of pathology in avirulent Semliki Forest virus encephalitis.
    Berger ML
    Infect Immun; 1980 Oct; 30(1):244-53. PubMed ID: 6254882
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Roles of interferon and natural killer cells in the antiviral activity of 7-thia-8-oxoguanosine against Semliki Forest virus infections in mice.
    Smee DF; Alaghamandan HA; Jin A; Sharma BS; Jolley WB
    Antiviral Res; 1990 Feb; 13(2):91-102. PubMed ID: 1693058
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Investigations of reasons for the avirulence of the A7 strain of Semliki Forest virus in adult mice.
    Woodward CG; Marshall ID; Smith H
    Br J Exp Pathol; 1977 Dec; 58(6):616-24. PubMed ID: 607983
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Demyelination in mice resulting from infection with a mutant of Semliki Forest virus.
    Sheahan BJ; Barrett PN; Atkins GJ
    Acta Neuropathol; 1981; 53(2):129-36. PubMed ID: 6259872
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immunocytochemical evidence for Semliki Forest virus antigen persistence in mouse brain.
    Khalili-Shirazi A; Gregson N; Webb HE
    J Neurol Sci; 1988 May; 85(1):17-26. PubMed ID: 3385428
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Can viral envelope glycolipids produce auto-immunity, with reference to the CNS and multiple sclerosis?
    Webb HE; Fazakerley JK
    Neuropathol Appl Neurobiol; 1984; 10(1):1-10. PubMed ID: 6330601
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In Semliki Forest virus encephalitis, antibody rapidly clears infectious virus and is required to eliminate viral material from the brain, but is not required to generate lesions of demyelination.
    Fragkoudis R; Ballany CM; Boyd A; Fazakerley JK
    J Gen Virol; 2008 Oct; 89(Pt 10):2565-2568. PubMed ID: 18796725
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The sensitivity to gamma-irradiation of the phases of the virus-host interaction: studies with strains of Semliki forest virus in mice.
    Bradish CJ; Titmuss D; Fitzgeorge R
    J Gen Virol; 1980 May; 48(1):39-51. PubMed ID: 7381435
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Semliki Forest virus (A7[74]) infection of adult mice induces an immune-mediated demyelinating encephalomyelitis.
    Fazakerley JK; Khalili-Shirazi A; Webb HE
    Ann N Y Acad Sci; 1988; 540():672-3. PubMed ID: 2849913
    [No Abstract]   [Full Text] [Related]  

  • 72. Comparison of protein A-gold and ferritin immunoelectron microscopy of Semliki Forest virus in mouse brain using a rapid processing technique.
    Evans NR; Webb HE
    J Histochem Cytochem; 1984 Apr; 32(4):372-8. PubMed ID: 6323573
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cross protection among togaviruses in nude mice and littermates.
    Latif Z; Gates D; Wust CJ; Brown A
    J Gen Virol; 1979 Oct; 45(1):89-98. PubMed ID: 316446
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Studies on linear epitopes of Semliki Forest virus in protection studies against lethal challenge virus infection.
    Truyen U; Kaaden OR
    Zentralbl Veterinarmed B; 1991 Aug; 38(6):463-7. PubMed ID: 1719714
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Course of an experimental infection caused by the Langat virus in mice against a background of restricted movement-related stress].
    Ozherelkov SV; Khozinskiĭ VV; Semenov BF
    Vopr Virusol; 1986; 31(5):634-6. PubMed ID: 3026100
    [No Abstract]   [Full Text] [Related]  

  • 76. A protective mechanism induced by live group B arboviruses against heterologous group B arboviruses independent of serum neutralizing antibodies or interferon.
    Price WH; Thind IS; O'Leary W; el Dadah AH
    Am J Epidemiol; 1967 Jul; 86(1):11-27. PubMed ID: 4378109
    [No Abstract]   [Full Text] [Related]  

  • 77. Principles for production of effective defined subunit vaccines. Deduction from a model experiment.
    Morein B; Helenius A; Simons K
    Comp Immunol Microbiol Infect Dis; 1980; 3(1-2):201-6. PubMed ID: 6258847
    [No Abstract]   [Full Text] [Related]  

  • 78. The pathological effect on the central nervous system of mice following single and repeated infections of the demyelinating A7(74) strain of Semliki Forest virus.
    Illavia SJ; Webb HE
    Neuropathol Appl Neurobiol; 1988; 14(3):207-20. PubMed ID: 2841621
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Demyelination induced in mice by avirulent Semliki Forest virus. II. An ultrastructural study of focal demyelination in the brain.
    Kelly WR; Blakemore WF; Jagelman S; Webb HE
    Neuropathol Appl Neurobiol; 1982; 8(1):43-53. PubMed ID: 6280089
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dimethyl dioctadecyl ammoniumbromide as an adjuvant for delayed type hypersensitivity and cellular immunity against Semliki Forest virus in mice.
    Kraaijeveld CA; Snippe H; Harmsen M; Khader Boutahar-Trouw B
    Arch Virol; 1980; 65(3-4):211-7. PubMed ID: 7416968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.